Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Bristol-Myers Squibb - Data Presented from Two Phase 3 ERBITUX(R) Studies in First-Line Metastatic Colorectal Cancer Patients at Joint 15th European Cancer Organisation and 34th European Society for Medical Oncology Multidisciplinary Congress
Breast Cancer - Findings from G. Deng and co-researchers advance knowledge in breast cancer
Breast Cancer - Reports summarize breast cancer study results from National Cancer Institute
Cancer Vaccines - Scientists at University of Texas report research in cancer vaccines
Falciparum Malaria - Study results from University of Toronto in the area of falciparum malaria published
Gastric Cancer - New gastric cancer data have been reported by P. Comella and co-authors
Heart Disease - Studies from Brigham and Women's Hospital further understanding of heart disease
Melanoma - Study results from A. Ribas and colleagues broaden understanding of melanoma
Non-Small Cell Lung Cancer - Reports from Y. Totani and colleagues advance knowledge in non-small cell lung cancer
Non-Small Cell Lung Cancer - Research from M.H. Chang and co-researchers in the area of non-small cell lung cancer published
Ovarian Cancer - Findings from C. Pisano et al in ovarian cancer reported
Ovarian Cancer - New ovarian cancer study results reported from B.L. Rapoport et al
Pancreatic Cancer - Research from H.J. Chang and co-authors reveals new findings on pancreatic cancer
Pharmacokinetics - Researchers from Duke University discuss findings in pharmacokinetics
Solid Cancer - Studies from N. Yamamoto and co-researchers update current data on solid cancer
Squamous Cell Carcinoma - Reports on squamous cell carcinoma findings from Viventia Biotech Inc. provide new insights
Thrombocytopenic Purpura - Investigators at Amgen, Inc. release new data on thrombocytopenic purpura
Immunization - Findings from Kurume University in immunization reported
Life Sciences - Research from Waikato Hospital, Department of Anaesthesia has provided new data on life sciences
Non-Hodgkin Lymphoma Therapy - Research conducted at National Cancer Center Hospital has updated our knowledge about non-hodgkin lymphoma therapy
Adolor Corporation - Adolor Acquires Rights to Clinical-Stage Product Candidate from Eli Lilly and Company
Anavex Life Sciences Corp. - ANAVEX completes scale-up manufacturing of ANAVEX 2-73 for Phase I Alzheimer's disease clinical trials
ARIAD Pharmaceuticals, Inc. - ARIAD Announces Clinical Data from Phase 1 Study of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Bevacizumab
Bioengineering - Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
Breast Cancer - Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression-Free Survival in Patients With Advanced Breast Cancer in Phase 2 Study
Cancer - Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
Cancer - Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial
Cancer - Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
Clinical Trial Research - Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
Colon Cancer - Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer
Constipation - AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation
HIV/AIDS - Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
Hormones - PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long-Acting Growth Hormone
Idera Pharmaceuticals - Idera Pharmaceuticals Presents Interim Data from Phase 1b Clinical Trial of IMO-2055 in Combination with Tarceva(R) and Avastin(R) in Non-Small Cell Lung Cancer
Impax Pharmaceuticals - Impax Pharmaceuticals Reports Positive Results of Phase II Trial of IPX066, a Novel Formulation of Carbidopa-Levodopa for Parkinson's Disease
Incyte Corporation - Incyte Announces Positive Top-Line Phase IIb Results for Topical INCB18424 in Psoriasis
Influenza - BioCryst Awarded Additional $77.2 Million by the U.S. Department of Health & Human Services To Develop Peramivir for Influenza
Lux Biosciences, Inc. - Lux Biosciences Reports Phase 1 Safety Results and Open Label Efficacy Results for LX214, a Potential Best-in-Class Treatment for Dry Eye
MD Becker Partners LLC - Semafore Retains Management Consulting Firm; Names Principal to Key Management Position
Ovarian Cancer - Farletuzumab Data Presented on Phase II Clinical Trial in First-Relapsed Ovarian Cancer Subjects
Ovarian Cancer - NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
Parkinson Disease - Michael J. Fox Foundation Commits Up to $5 Million to Help Advance Neurotrophic Factors 'From Promise to Reality' As Parkinson's Treatment
Pfizer - Pfizer To Present Research On Established Therapies and New Approaches To Cancer Treatment Using Investigational Agents
Pluristem Therapeutics Inc. - Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Prostate Cancer - Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
Prostate Cancer - New and Interesting PROSTVAC(TM) Data Indicate Broad Therapeutic Use in Metastatic Prostate Cancer
Therapy - Aegera Therapeutics Closes CDN$7 Million Financing
